Meng Xiang-hui, Xu Bai-nan, Wei Shao-bo, Zhou Tao, Chen Xiao-lei, Yu Xin-guang, Zhou Ding-biao, Tong Huai-yu, Zhang Jia-shu, Zhao Yan, Hou Yuan-Zheng
Department of Neurosurgery, People's Liberation Army General Hospital, Beijing, China.
Zhonghua Wai Ke Za Zhi. 2011 Aug 1;49(8):703-6.
To review the preliminary clinical experience with high-field-strength intraoperative magnetic resonance imaging (iMRI) suite with neuronavigation system in the pituitary adenoma operation with transsphenoidal approach.
From March 2009 to December 2010, 31 patients [range, 29 - 76 years, mean age (47 ± 11) years]of pituitary adenoma were operated with transsphenoidal approach and intraoperatively with a movable 1.5 T high-field-strength iMRI suite in combination with neuronavigation system. Tumor size was 1.8 - 7.3 cm, mean (3.5 ± 1.2) cm. Twenty-five cases were non-functional pituitary adenoma, 4 cases were prolactin-secreting pituitary adenoma, 2 cases were growth hormone-secreting pituitary adenoma. Thirty patients' resection with transnasal transsphenoidal approach were performed, one patient with transoral transsphenoidal approach was performed.
In 12 cases of 30 patients who planed to totally remove tumor, iMRI had revealed residual lesions and resulted in the change of the surgical strategy, 2 invasive cavernous sinus cases no further resection of the tumor because of internal carotid artery encasement, the other 10 cases resected further, eventually. Finally, 8 cases were totally removed. The ratio of total removal tumor was enhanced to 86.7% (26/30) from 60.0% (18/30). There was no perioperative mortality.
High-field-strength iMRI suite with neuronavigation system provides valuable information of tumor resection that allows intraoperative modification of the surgical strategy. It could be very helpful to maximize the resection of the pituitary adenoma and minimize the injury to neurological function.
回顾在经蝶窦入路垂体腺瘤手术中使用带有神经导航系统的高场强术中磁共振成像(iMRI)设备的初步临床经验。
2009年3月至2010年12月,31例垂体腺瘤患者[年龄范围29 - 76岁,平均年龄(47±11)岁]接受经蝶窦入路手术,并在术中使用可移动的1.5T高场强iMRI设备结合神经导航系统。肿瘤大小为1.8 - 7.3cm,平均(3.5±1.2)cm。25例为无功能性垂体腺瘤,4例为泌乳素分泌型垂体腺瘤,2例为生长激素分泌型垂体腺瘤。30例患者采用经鼻蝶窦入路进行切除,1例患者采用经口蝶窦入路进行切除。
在计划完全切除肿瘤的30例患者中,12例iMRI显示有残留病变,导致手术策略改变,2例侵袭性海绵窦病例因颈内动脉被包绕未进一步切除肿瘤,但最终另外10例进一步切除,最终8例完全切除。肿瘤完全切除率从60.0%(18/30)提高到86.7%(26/30)。围手术期无死亡病例。
带有神经导航系统的高场强iMRI设备可提供有关肿瘤切除的有价值信息,有助于术中调整手术策略,对最大限度切除垂体腺瘤和最小化神经功能损伤非常有帮助。